Login / Signup

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.

Fourat RidouaniThibaud DamyVania TacherHaytham DerbelFrançois LegouIslem SifaouiEtienne AudureauDiane BodezAlain RahmouniJean-François Deux
Published in: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance (2018)
Trial Registration and unique number: CNIL cardio 1778041. Date of registration: 20 December 2012.
Keyphrases
  • left ventricular
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • multiple myeloma
  • randomized controlled trial
  • heart failure